إعلان
إعلان
INBX
Inhibrx Biosciences, Inc. Common Stock
72.89
USDبرعاية
-2.31
-3.08%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
72.86
-0.03
-0.03%
تقارير أرباح INBX
النسبة الإيجابية المفاجئة
INBX تفوق 10 من 21 آخر التقديرات.
48%
التقرير التالي
بيانات التقرير القادم
١٦ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$2.11
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/-7.05%
التغير الضمني من Q4 24 (Revenue/ EPS)
-100.00%
/-31.72%
Inhibrx Biosciences, Inc. Common Stock earnings per share and revenue
On ١٤ نوفمبر ٢٠٢٥, INBX reported earnings of -2.27 USD per share (EPS) for Q3 25, missing the estimate of -1.75 USD, resulting in a -30.11% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +6.04% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 المحللين forecast an EPS of -2.11 USD, with revenue projected to reach -- USD, implying an نقصان of -7.05% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Inhibrx Biosciences, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Inhibrx Biosciences, Inc. Common Stock reported EPS of -$2.27, missing estimates by -30.11%, and revenue of $0.00, 0% as expectations.
How did the market react to Inhibrx Biosciences, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 6.04%, changed from $74.62 before the earnings release to $79.13 the day after.
When is Inhibrx Biosciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for ١٦ مارس ٢٠٢٦.
What are the forecasts for Inhibrx Biosciences, Inc. Common Stock's next earnings report?
Based on 3
المحللين, Inhibrx Biosciences, Inc. Common Stock is expected to report EPS of -$2.11 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان